The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Reporting owner

Mazumdar Claire

Reporting owner CIK 0002034671 · Chief Executive Officer · Director

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Mazumdar ClaireMazumdar ClaireMazumdar Claire · December 16, 2025 · Exercise / conversion · Common StockMazumdar Claire · November 24, 2025 · Exercise / conversion · Common StockMazumdar Claire · October 16, 2025 · Exercise / conversion · Common StockMazumdar Claire · October 15, 2025 · Exercise / conversion · Common StockMazumdar Claire · October 13, 2025 · Exercise / conversion · Common StockOct 13, 2025Dec 16, 2025
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

5 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Dec 16, 2025Bicara Therapeutics Inc.Common StockMazumdar ClaireExercise / conversion
Nov 24, 2025Bicara Therapeutics Inc.Common StockMazumdar ClaireExercise / conversion
Oct 16, 2025Bicara Therapeutics Inc.Common StockMazumdar ClaireExercise / conversion
Oct 15, 2025Bicara Therapeutics Inc.Common StockMazumdar ClaireExercise / conversion
Oct 13, 2025Bicara Therapeutics Inc.Common StockMazumdar ClaireExercise / conversion

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: Bicara Therapeutics Inc.BCAX · company listings
Mazumdar ClaireChief Executive Officer · Director
Exercise / conversionCommon StockNon-derivative security · Code M29,5005.4537Value: 160,884.15Currency not specifiedView ↗
Trade: Bicara Therapeutics Inc.BCAX · company listings
Mazumdar ClaireChief Executive Officer · Director
Exercise / conversionCommon StockNon-derivative security · Code M41,1633.7898Value: 155,999.5374Currency not specifiedView ↗
Trade: Bicara Therapeutics Inc.BCAX · company listings
Mazumdar ClaireChief Executive Officer · Director
Exercise / conversionCommon StockNon-derivative security · Code M24,1033.7898Value: 91,345.5494Currency not specifiedView ↗
Trade: Bicara Therapeutics Inc.BCAX · company listings
Mazumdar ClaireChief Executive Officer · Director
Exercise / conversionCommon StockNon-derivative security · Code M13,2893.7898Value: 50,362.6522Currency not specifiedView ↗
Trade: Bicara Therapeutics Inc.BCAX · company listings
Mazumdar ClaireChief Executive Officer · Director
Exercise / conversionCommon StockNon-derivative security · Code M11,4453.7898Value: 43,374.261Currency not specifiedView ↗